Rafael
Rodríguez-Rosado Martínez-Echevarría
Publicaciones (30) Publicaciones de Rafael Rodríguez-Rosado Martínez-Echevarría
2022
-
Data-Driven Path Analytic Modeling to Understand Underlying Mechanisms in COVID-19 Survivors Suffering from Long-Term Post-COVID Pain: A Spanish Cohort Study
Pathogens, Vol. 11, Núm. 11
-
The Self-Reported Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) and PainDETECT Questionnaires in COVID-19 Survivors with Post-COVID Pain
Viruses, Vol. 14, Núm. 7
2006
-
Efectividad inmunológica de las combinaciones de análogos de nucleósidos/nucleótidos, tenofovir + lamivudina, didanosina + lamivudina y tenofovir + didanosina, en pacientes con infección por el VIH y supresión virológica mantenida
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 7, pp. 426-430
2001
-
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C
American Journal of Gastroenterology, Vol. 96, Núm. 1, pp. 179-183
-
Intensification of antiretroviral therapy
AIDS Research and Human Retroviruses, Vol. 17, Núm. 6, pp. 499-506
-
Management of hepatitis C in HIV-infected persons
Antiviral Research, Vol. 52, Núm. 2, pp. 189-198
-
Performance of a quadruple combination including nelfinavir plus efavirenz in naive subjects with high baseline viral load and in patients failing protease inhibitor-containing regimens [3]
Journal of Acquired Immune Deficiency Syndromes
2000
-
Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy
AIDS, Vol. 14, Núm. 4, pp. 383-386
-
Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients
Journal of Human Virology, Vol. 3, Núm. 6, pp. 335-340
-
Intensificación del tratamiento antirretrovírico
Revista Clinica Espanola, Vol. 200, Núm. 2, pp. 84-87
-
Interferon plus ribavirin for chronic hepatitis C in HIV-infected patients
AIDS, Vol. 14, Núm. 15, pp. 2409-2410
-
Second Spanish Consensus on the Use of Drug Resistance Testing in Clinical Practice (Madrid, March 2000)
AIDS Reviews
-
Terapia antirretrovírica de rescate
Revista Clinica Espanola, Vol. 200, Núm. 2, pp. 88-94
1999
-
Diabetes mellitus associated with protease inhibitor use
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 18, Núm. 9, pp. 675-677
-
El virus de la hepatitis C: tras los pasos del virus de la inmunodeficiencia humana.
Revista clínica española
-
Hepatitis C and HTV infection: Biological, clinical, and therapeutic implications
Journal of Hepatology, Supplement, Vol. 31, Núm. 1, pp. 119-123
-
Higher antiviral activity of antiretroviral regimens including protease inhibitors [5]
AIDS
-
Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users
European Journal of Epidemiology, Vol. 15, Núm. 1, pp. 1-4
-
Incidence of rash and discontinuation of nevirapine using two different escalating initial doses.
AIDS (London, England)
-
Introduction of HIV drug-resistance testing in clinical practice
AIDS, Vol. 13, Núm. 9, pp. 1007-1014